RAAPID
Provides AI-powered risk adjustment solutions for healthcare
UndisclosedSeries A+
Role not disclosedUE
UPMC Enterprises
Activity from announced rounds
Activity in this selectionMar 31, 2026 · Mar 1, 2026
UPMC Enterprises is the organization identified in its own RAAPID, BrainCheck and ai3Bio materials.
Recorded funding activity
RAAPID supplies healthcare risk-adjustment software. Ai3Bio develops immune-cell-targeted medicines. The pending ai3Bio relation stays in draft, and the organization remains separate from UPMC and the University of Pittsburgh.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share